Lakhani, N. J., Melisi, D., Subbiah, V., Ammakkanavar, N. R., O'Reilly, E. M., Cassier, P. A., Wainberg, Z. A., Duffy, A. G., Patnaik, A., Fujiwara, Y., Oberstein, P. E., Garcia-Carbonero, R., Wright, J., Lin, A. K., Li, J., Axelson, M. D., Garrido-Laguna, I. (2025). MOONRAY-01, a phase 1 study of LY3962673, a potent, orally bioavailable, and selective KRAS G12D inhibitor in KRAS G12D -mutant solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps845